United States Wearable Continuous Glucose Monitoring Devices Market valuation $32.48 billion by 2033 - Exclusive Report by DatamIntelligence

"Wearable Continuous Glucose Monitoring Devices Market reached US$12.20 billion in 2024 and is expected to reach US$32.48 billion by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033" As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/wearable-continuous-glucose-monitors-market?sp

United States: Recent Industry Developments

✅ In October 2025, Abbott expanded its FreeStyle Libre CGM platform in the U.S. with improved app integration and real-time alerts. The wearable allows home-based glucose monitoring without fingersticks. It enhances convenience and proactive metabolic health management.

✅ In September 2025, Dexcom launched the Stelo CGM, the first over-the-counter device approved by the FDA for adults without prescription. The system targets wellness-oriented users and non-diabetic consumers. It broadens accessibility to continuous glucose monitoring.

✅ In August 2025, Trinity Biotech introduced its CGM+ wearable combining glucose monitoring with heart rate and activity analytics using AI. The multi-sensor platform enables comprehensive metabolic and cardiovascular tracking. It supports personalized health management.

✅ In July 2025, Senseonics released its implantable CGM Real-Time system in the U.S., designed for 365-day wear. The extended-use device reduces sensor replacements and supports long-term glucose management. It targets patients needing continuous monitoring.

Japan: Recent Industry Developments

✅ In October 2025, Abbott FreeStyle Libre gained expanded approval in Japan via Terumo Corporation for day-to-day glucose management without fingersticks. The wearable enables convenient home monitoring. It marks a key regulatory milestone for CGMs in Japan.

✅ In September 2025, research on non-invasive CGM wearables, including sweat-based and optical sensors, progressed in Japan. These innovations aim to provide pain-free continuous monitoring. They support Japan's aging and chronic disease population.

✅ In August 2025, Terumo Japan rolled out the Dexcom G6 CGM system, offering real-time glucose readings and trend alerts. The device transmits data to smartphone apps for seamless monitoring. It improves remote diabetes care.

✅ In July 2025, Japan's healthcare ecosystem increased focus on reimbursement and home-based access for CGM devices. Telehealth integration is driving adoption of wearable glucose monitors. It supports chronic disease management and patient-centered care.

Wearable Continuous Glucose Monitoring Devices Market: Drivers

The wearable continuous glucose monitoring (CGM) devices market is experiencing rapid growth as diabetes prevalence continues to rise globally, driving demand for real-time, non-invasive, and patient-friendly glucose monitoring solutions. Wearable CGM devices provide continuous blood glucose readings, alerts for hypo- and hyperglycemia, and data integration with mobile apps, enabling patients and healthcare providers to make timely treatment decisions and improve disease management. Increasing awareness of diabetes self-management, adoption of digital health technologies, and preference for minimally invasive solutions are further supporting market expansion. Additionally, integration with insulin pumps, telemedicine platforms, and wearable health ecosystems is enhancing usability and patient engagement. Rising healthcare expenditure, government initiatives, and reimbursement support are further promoting adoption across regions.

Technological advancements in sensor accuracy, data analytics, wireless connectivity, and compact wearable designs are enhancing reliability, comfort, and real-time monitoring capabilities. Collaborations between medical device manufacturers, software developers, and healthcare providers are driving innovation, personalized care, and clinical validation of next-generation CGM systems. Growing interest in preventive healthcare, chronic disease management, and AI-enabled predictive insights is creating new growth opportunities. Expansion of consumer awareness campaigns and mobile health platforms is boosting patient adoption and adherence. With continuous innovation and increasing demand for convenient, real-time glucose monitoring, the wearable continuous glucose monitoring devices market is poised for sustained global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/wearable-continuous-glucose-monitors-market?sp

Wearable Continuous Glucose Monitoring Devices Market: Major Players

Dexcom, Inc., Abbott., Medtronic, Senseonics, F. Hoffmann-La Roche Ltd, and Afon Technology., among others.

Segment Covered in the Wearable Continuous Glucose Monitoring Devices Market:

By Component
The market is segmented into Receiver or Display Devices, Sensors, Transmitters, and Others. Sensors dominate due to their critical role in continuous glucose data collection and real-time monitoring accuracy. Transmitters and display devices grow steadily with innovations in wireless connectivity and smartphone integration.

By Indication
Type 1 Diabetes accounts for the largest share owing to the need for constant glucose level tracking and insulin dose optimization. Type 2 Diabetes users increasingly adopt CGM systems for lifestyle-based management and to reduce hypoglycemia risk. Both indications benefit from greater clinical awareness and accessibility.

By Age Group
Adults lead the segment as they form the majority of the diabetic population and actively use wearable CGMs for self-management. Children represent a growing user base due to advancements in minimally invasive sensors and parental monitoring apps. Geriatric users benefit from continuous monitoring that enhances safety and early detection of glucose fluctuations.

Regional Analysis

North America (≈41% share):
Leads the market with strong adoption in the U.S. and Canada, driven by high diabetes prevalence and favorable reimbursement policies. Technological advancements from players like Dexcom and Abbott accelerate device penetration. Widespread telehealth integration further supports market leadership.

Europe (≈28% share):
Ranks second, supported by increasing diabetic awareness and government-backed digital health initiatives. Countries like Germany, the U.K., and France are early adopters of CGM systems. Growing collaborations between device makers and healthcare providers drive consistent market growth.

Asia Pacific (≈19% share):
Fastest-growing region fueled by a rising diabetic population and improving healthcare infrastructure. China, Japan, and India lead regional adoption with affordable product launches and digital monitoring programs. Increased smartphone penetration enhances accessibility to connected devices.

Latin America (≈7% share):
Witnesses steady expansion led by Brazil and Mexico, supported by rising healthcare expenditure. Gradual policy shifts toward chronic disease management and adoption of remote monitoring tools contribute to market growth. Public-private collaborations improve patient reach.

Middle East & Africa (≈5% share):
An emerging market with increasing focus on diabetes care modernization. Gulf countries drive adoption through national health digitalization efforts. Growing awareness of glucose management and wearable convenience fuels adoption across urban centers.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=wearable-continuous-glucose-monitors-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.